370231006: Opiate agonist-antagonist (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1195522014 Opiate agonist-antagonist (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1208982016 Opiate agonist-antagonist en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2764331000005110 Opiatagonist/-antagonist da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Opiatagonist/-antagonist	Is a	Analgesic (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dezocine	Is a	False	Opiatagonist/-antagonist	Inferred relationship	Some
Pentazocine lactate	Is a	False	Opiatagonist/-antagonist	Inferred relationship	Some
Pentazocine hydrochloride	Is a	False	Opiatagonist/-antagonist	Inferred relationship	Some
Phenazocine hydrobromide	Is a	False	Opiatagonist/-antagonist	Inferred relationship	Some
Qualitative measurement of opiate agonist	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Alfentanil measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Alphaprodine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Anileridine measurement (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Codeine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Dextromoramide measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Diamorphine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Mersalyl measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Oxycodone measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Methylfentanyl measurement (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Norfentanyl measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
6-beta-Naltrexol measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
6-Monoacetylmorphine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Moricizine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Oxymorphone measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Paramethadione measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Despropionylfentanyl measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Methadone, long acting metabolite measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
måling af oxycodon	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Opioid screening	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Urine methadone measurement (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Urine morphine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Methadone measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Urine codeine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Urine opiate measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Serum morphine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
buprenorphin 300 µg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
nalbuphinhydrochlorid 10 mg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
nalbuphinhydrochlorid 10 mg/ml injektionsvæske, opløsning, ampul a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
pentazocin 30 mg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
pentazocin 30 mg/ml injektionsvæske, opløsning, ampul a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Pentazocine (as pentazocine lactate) 50 mg rectal suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
benzomorphanopioid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Dimethadione measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
opiatagonist/-antagonist-produkt	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Butorphanol product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing precisely butorphanol tartrate 10 milligram/1 milliliter conventional release nasal spray (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Buprenorphine product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Nalbuphine product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
butorphanoltartrat 2 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
butorphanoltartrat 1 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
nalbuphinhydrochlorid 20 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
acetylsalicylsyre + pentazocinhydrochlorid 325 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
paracetamol + pentazocinhydrochlorid kapselformet 650 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Dextropropoxyphene (substance)	Is a	False	Opiatagonist/-antagonist	Inferred relationship	Some
Dihydrocodeine (substance)	Is a	False	Opiatagonist/-antagonist	Inferred relationship	Some
Phenazocine (substance)	Is a	False	Opiatagonist/-antagonist	Inferred relationship	Some
Dextromoramide (substance)	Is a	False	Opiatagonist/-antagonist	Inferred relationship	Some
Serum methadone level (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Urine diamorphine level (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Oral fluid opiate level (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Oral fluid morphine level (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Oral fluid methadone level (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Urine methadone metabolite level (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing pentazocine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Meperidine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
måling af dihydromorphinon	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
opiater	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Trimethadione measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Quantitative measurement of opiate agonist	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Nalorphine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
måling af dihydrocodeinon	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Morphine measurement, quantitative	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
screeningsmåling af morfin	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing butorphanol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing buprenorphine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing nalbuphine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Nalbuphine hydrochloride [central nervous system use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Nalbuphine hydrochloride [anesthesia]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Buprenorphine 70micrograms/hour transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Buprenorphine 52.5micrograms/hour transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Buprenorphine 35micrograms/hour transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Buprenorphine hydrochloride + naloxone hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
buprenorphinhydrochlorid 2 mg + naloxonhydrochlorid 0,5 mg sublingval resoriblet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
buprenorphinhydrochlorid 8 mg + naloxonhydrochlorid 2 mg sublingval resoriblet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
buprenorphin 35 µg/time depotplaster	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
buprenorphin 52,2 µg/time depotplaster	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
buprenorphin 70 µg/time depotplaster	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Pentazocine hydrochloride 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
nalbuphinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
paracetamol + pentazocinhydrochlorid kapselformet 650 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
acetylsalicylsyre + pentazocinhydrochlorid 325 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
paracetamol + pentazocinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
naloxonhydrochlorid + pentazocinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
acetylsalicylsyre + pentazocinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some
Dihydrocodeine measurement	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Urine dihydrocodeine measurement (procedure)	Component	False	Opiatagonist/-antagonist	Inferred relationship	Some
Product containing buprenorphine and naloxone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Opiatagonist/-antagonist	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

SAME AS association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1195522014	Opiate agonist-antagonist (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1208982016	Opiate agonist-antagonist	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2764331000005110	Opiatagonist/-antagonist	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)